Literature DB >> 21917272

Vertical one-and-a-half syndrome with contralesional pseudo-abducens palsy in a patient with thalamomesencephalic stroke.

Dirk Deleu1, Yahia Zakaria Bashier Imam, Boulenouar Mesraoua, Khalid Yacout Salem.   

Abstract

We report a unique neuroophthalmological syndrome consisting of vertical one-and-a-half syndrome-resulting from a combination of supranuclear conjugate upgaze palsy associated with left infranuclear (fascicular) third nerve involvement (Weber syndrome)-with concomitant contralesional pseudo-abducens palsy. Magnetic resonance imaging confirmed that this unusual clinical combination was the result of two infarcts one in the left thalamomesencephalic junction and another affecting the left infrategmental paramedian area of the rostral midbrain. We discuss the clinical topography of both neuroophthalmological findings. This unusual neuroophthalmological finding has not been reported.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21917272     DOI: 10.1016/j.jns.2011.08.032

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Teaching Video NeuroImages: Thalamic infarct with pseudo-abducens and vertical gaze palsies and an unusual stroke mechanism.

Authors:  Shahin Khayambashi; Jonathan D Fridhandler; Philip Teal; Jason J S Barton; Sharanpal K Mann
Journal:  Neurology       Date:  2016-08-09       Impact factor: 9.910

2.  Complete Bilateral Ophthalmoplegia Due to a Strategic Midbrain Infarct.

Authors:  Boby Varkey Maramattom; Hanna Angel Meleth
Journal:  Ann Indian Acad Neurol       Date:  2021-04-16       Impact factor: 1.383

3.  Unilateral asterixis, thalamic astasia and vertical one and half syndrome in a unilateral posterior thalamo-subthalamic paramedian infarct: An interesting case report.

Authors:  Subasree Ramakrishnan; Veera Rajkumar Narayanaswamy
Journal:  J Neurosci Rural Pract       Date:  2013-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.